ATE433992T1 - An menschlichen faktor-viii bindende moleküle und faktor-viii-ähnliche proteine - Google Patents

An menschlichen faktor-viii bindende moleküle und faktor-viii-ähnliche proteine

Info

Publication number
ATE433992T1
ATE433992T1 AT06009040T AT06009040T ATE433992T1 AT E433992 T1 ATE433992 T1 AT E433992T1 AT 06009040 T AT06009040 T AT 06009040T AT 06009040 T AT06009040 T AT 06009040T AT E433992 T1 ATE433992 T1 AT E433992T1
Authority
AT
Austria
Prior art keywords
factor viii
proteins
binding molecules
human factor
human
Prior art date
Application number
AT06009040T
Other languages
German (de)
English (en)
Inventor
Jinan Yu
Daniel M Potter
Brian D Kelley
Jeffrey S Deetz
James E Booth
Original Assignee
Dyax Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dyax Corp filed Critical Dyax Corp
Application granted granted Critical
Publication of ATE433992T1 publication Critical patent/ATE433992T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Reciprocating Pumps (AREA)
AT06009040T 1999-01-04 2000-01-03 An menschlichen faktor-viii bindende moleküle und faktor-viii-ähnliche proteine ATE433992T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/224,785 US6197526B1 (en) 1999-01-04 1999-01-04 Polypeptides for binding human factor VIII and fragments of human factor VIII

Publications (1)

Publication Number Publication Date
ATE433992T1 true ATE433992T1 (de) 2009-07-15

Family

ID=22842198

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06009040T ATE433992T1 (de) 1999-01-04 2000-01-03 An menschlichen faktor-viii bindende moleküle und faktor-viii-ähnliche proteine

Country Status (12)

Country Link
US (2) US6197526B1 (enExample)
EP (5) EP1705183B1 (enExample)
JP (3) JP4733272B2 (enExample)
AT (1) ATE433992T1 (enExample)
AU (3) AU769745B2 (enExample)
CA (1) CA2354599C (enExample)
DE (1) DE60042430D1 (enExample)
DK (4) DK2298791T3 (enExample)
ES (4) ES2390360T3 (enExample)
HK (1) HK1038756A1 (enExample)
PT (3) PT2301953E (enExample)
WO (1) WO2000040602A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7820796B2 (en) * 1998-03-12 2010-10-26 Genetics Institute, Llc. Methods for producing Factor VIII proteins
US6197526B1 (en) * 1999-01-04 2001-03-06 Dyax Corp. Polypeptides for binding human factor VIII and fragments of human factor VIII
US7112438B2 (en) * 1999-01-04 2006-09-26 Dyax Corp. Binding molecules for human factor VIII and factor VIII-like proteins
FR2830865B1 (fr) * 2001-10-17 2004-10-22 Centre Nat Rech Scient Leurres peptidiques pour la preparation de medicaments destines a la prevention ou au traitement des pathologies auto-immunes, ou des troubles lies a l'apparition d'anticorps diriges contre des proteines exogenes
US20030149246A1 (en) * 2002-02-01 2003-08-07 Russell John C. Macromolecular conjugates and processes for preparing the same
WO2003093821A1 (en) * 2002-04-29 2003-11-13 Affibody Ab Sandwich assay and kit
EP1968999A2 (en) * 2005-12-07 2008-09-17 Technische Universität München Small peptidic and peptido-mimetic affinity ligands for factor viii and factor viii-like proteins
TW200745163A (en) 2006-02-17 2007-12-16 Syntonix Pharmaceuticals Inc Peptides that block the binding of IgG to FcRn
AU2008236694B2 (en) 2007-04-04 2014-01-23 The Regents Of The University Of California Compositions, devices, systems, and methods for using a nanopore
CA2694824A1 (en) 2007-08-09 2009-02-12 Syntonix Pharmaceuticals, Inc. Immunomodulatory peptides
TWI573806B (zh) 2008-04-17 2017-03-11 巴克斯歐塔公司 生物活性胜肽
WO2010014909A1 (en) * 2008-08-01 2010-02-04 Syntonix Pharmaceuticals, Inc. Immunomodulatory peptides
US8324914B2 (en) 2010-02-08 2012-12-04 Genia Technologies, Inc. Systems and methods for characterizing a molecule
SG191186A1 (en) 2010-12-15 2013-07-31 Baxter Int Eluate collection using conductivity gradient
DK2717898T3 (en) * 2011-06-10 2019-03-25 Bioverativ Therapeutics Inc COAGULATING COMPOUNDS AND PROCEDURES FOR USE THEREOF
JP6702866B2 (ja) 2013-11-18 2020-06-03 ルビウス セラピューティクス, インコーポレイテッド 合成膜−レシーバー複合体
EP3515932B1 (en) 2016-09-19 2023-11-22 F. Hoffmann-La Roche AG Complement factor based affinity chromatography
US11123704B2 (en) 2017-08-04 2021-09-21 Takeda Pharmaceutical Company Limited Antibody-resin coupling apparatus and methods

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4757006A (en) 1983-10-28 1988-07-12 Genetics Institute, Inc. Human factor VIII:C gene and recombinant methods for production
SE8501050D0 (sv) 1985-03-05 1985-03-05 Kabivitrum Ab Biologically active fragments of human antihemophilic factor and method for preparation thereof
JPH0788399B2 (ja) 1985-04-12 1995-09-27 ジェネティックス・インスチチュ−ト・インコ−ポレ−テッド 新規プロコアギュラント蛋白質
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
EP1997891A1 (en) * 1988-09-02 2008-12-03 Dyax Corporation Generation and selection of recombinant varied binding proteins
US5661008A (en) 1991-03-15 1997-08-26 Kabi Pharmacia Ab Recombinant human factor VIII derivatives
SE468050C (sv) * 1991-03-15 1998-04-27 Pharmacia & Upjohn Ab Rekombinant derivat av human faktor VIII
EP0648268A1 (en) * 1991-03-27 1995-04-19 The Scripps Research Institute Therapeutic fragments of von willebrand factor
ES2229347T3 (es) * 1996-03-20 2005-04-16 Dyax Corp. Purificacion del activador del plasminogeno tisular tpa.
US5817752A (en) 1996-06-06 1998-10-06 La Jolla Pharmaceutical Company Cyclic polypeptides comprising a thioether linkage and methods for their preparation
JP2000512981A (ja) 1996-06-06 2000-10-03 ラ ホヤ ファーマシューティカル カンパニー aPL免疫応答性ペプチド、その結合体およびaPL抗体媒介病理のための処置方法
PT1095143E (pt) * 1998-05-08 2008-11-28 Sanquin Bloedvoorziening Inibidor para o diagnóstico e tratamento de doentes com hemofilia a
US5994310A (en) 1998-09-03 1999-11-30 Bayer Corporation Peptide ligands for affinity purification of human Factor VIII
US6197526B1 (en) * 1999-01-04 2001-03-06 Dyax Corp. Polypeptides for binding human factor VIII and fragments of human factor VIII

Also Published As

Publication number Publication date
EP1147128A4 (en) 2004-10-13
EP1705183A1 (en) 2006-09-27
EP2090582A2 (en) 2009-08-19
DK1705183T3 (da) 2009-10-19
EP2298791A1 (en) 2011-03-23
US20010014456A1 (en) 2001-08-16
HK1038756A1 (zh) 2002-03-28
ES2328722T3 (es) 2009-11-17
AU2004201810A1 (en) 2004-05-27
DK2090582T3 (da) 2012-10-15
JP2010254694A (ja) 2010-11-11
EP2298791B8 (en) 2014-12-24
EP2090582B1 (en) 2012-09-19
PT2301953E (pt) 2014-09-15
JP2002536297A (ja) 2002-10-29
JP5368371B2 (ja) 2013-12-18
ES2390360T3 (es) 2012-11-12
EP2301953A1 (en) 2011-03-30
CA2354599C (en) 2013-03-12
HK1155182A1 (en) 2012-05-11
JP2013079272A (ja) 2013-05-02
CA2354599A1 (en) 2000-07-13
EP1705183B1 (en) 2009-06-17
AU2004201830A1 (en) 2004-05-27
AU2598200A (en) 2000-07-24
ES2524965T3 (es) 2014-12-16
WO2000040602A1 (en) 2000-07-13
JP5572207B2 (ja) 2014-08-13
JP4733272B2 (ja) 2011-07-27
US6197526B1 (en) 2001-03-06
HK1131398A1 (en) 2010-01-22
EP1147128A1 (en) 2001-10-24
AU769745B2 (en) 2004-02-05
US6492105B2 (en) 2002-12-10
EP2090582A3 (en) 2009-11-11
EP2301953B1 (en) 2014-07-30
AU2004201830B2 (en) 2007-04-05
EP2298791B1 (en) 2014-11-12
ES2499040T3 (es) 2014-09-26
PT2298791E (pt) 2014-12-16
DK2298791T3 (en) 2014-12-08
PT1705183E (pt) 2009-07-31
HK1155756A1 (en) 2012-05-25
DK2301953T3 (da) 2014-09-22
DE60042430D1 (de) 2009-07-30

Similar Documents

Publication Publication Date Title
DE60042430D1 (de) An menschlichen Faktor-VIII bindende Moleküle und Faktor-VIII-ähnliche Proteine
EP2267020A3 (en) Binding polypeptides for B lymphocyte stimulator protein (BLyS)
WO2001004265A3 (en) C-terminal protein tagging
ITTO950367A0 (it) Proteine di prrsv ricombinanti, corredi diagnostici e vaccini contenenti tali proteine di prrsv ricombinanti.
IL153052A0 (en) Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
EP1623227A4 (en) PROTEINS, SENSORS AND METHODS FOR CHARACTERIZING SUBSTANCES TO BE ANALYZED USING THESE PROTEINS AND THESE SENSORS
WO2005047459A3 (en) Sars nucleic acids, proteins, antibodies, and uses thereof
ATE221663T1 (de) Prionbindende proteine und deren verwendungen
EP1243923A4 (en) METHOD FOR SELECTING A CANCER REMEDY USING P53 AND MORTALIN INTERACTION AREAS
IL147527A0 (en) Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes
WO2001029220A3 (en) Mage-a12 antigenic peptides and uses thereof
AU2001240662A1 (en) Method for the esr-spectroscopic detection of changes in the transport properties of albumin in an albumin-containing sample, esr-spectrometer for carrying out said method, and use of the method for diagnostic purposes and for controlling albumin-containing preparations
IT1317849B1 (it) Mezzi e metodi per l'espressione di proteine omologhe ed eterologhe inceppi di rhodococcus.
WO2000057188A3 (fr) Proteines associees a un cancer mammaire et procede de detection de ces proteines
EP1186662A3 (en) Prion binding proteins and uses thereof
WO2003060148A3 (en) Androgen regulated nucleic acid molecules and encoded proteins
WO2003044160A3 (en) Novel molecules of the card related protein family and uses thereof

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1705183

Country of ref document: EP

UEP Publication of translation of european patent specification

Ref document number: 1705183

Country of ref document: EP